UBS Group’s TrovaGene, Inc. Warrant TROVW Stock Holding History

UBS Group’s Portfolio TROVW Stock Details TROVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-971	Closed	–	–	8348
2017 Q1	$0	Buy	971 +954	+5,612%	+$241	﹤0.01%	8325
2016 Q4	$0	Sell	17 -100	-85%	-$82	﹤0.01%	8324
2016 Q3	$0	Sell	117 -703	-86%	-$1.41K	﹤0.01%	8200
2016 Q2	$2K	Buy	820 +720	+720%	+$2.21K	﹤0.01%	7501
2016 Q1	$0	Buy	+100	New	+$324	﹤0.01%	8595
2015 Q1	–	Sell	-699	Closed	-$2K	–	9814
2014 Q4	$2K	Buy	+699	New	+$2.07K	﹤0.01%	9473

UBS Group's TROVW Position: Q2 2017 in Review

UBS Group sold out of TrovaGene, Inc. Warrant (TROVW) in Q2 2017, closing a stake of 971 shares.

UBS Group first reported a position in TROVW in Q4 2014 and held it in 6 quarters. The position peaked at $2K in Q2 2016. 0 funds tracked by Wall St. Rank hold TROVW as of Q2 2017.

UBS Group reported no remaining TrovaGene, Inc. Warrant position as of Q2 2017 after selling out during the quarter.
UBS Group sold 971 TrovaGene, Inc. Warrant shares in Q2 2017.
UBS Group first reported a position in TrovaGene, Inc. Warrant in Q4 2014 and held it in 6 quarters.
UBS Group's TrovaGene, Inc. Warrant position peaked at $2K in Q2 2016.
0 funds tracked by Wall St. Rank held TrovaGene, Inc. Warrant as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.